Back to Mobile View
Subscribe to the CrunchBase Daily for the latest on Fundings, Acquisitions, and Startup Events

General Information

Offices

1015 Lausanne, CHE
EPFL Innovation Park
Building B
1015 Lausanne, CHE

People

Funding

TOTAL $22M
FUNDING TOTAL $22M
Series D, 1/2014
$22M

Tags

AC Immune SA

AC Immune SA is a Swiss-based biopharmaceutical company and a leader in Alzheimer´s Disease drug development. They are developing innovative therapeutics with “best in class” potential against Alzheimer´s Disease and other conformational diseases along three axes: vaccines, antibodies and small molecules.

Recent Milestones

Videos

Screenshots

AC Immune SA screenshot
Above: Homepage
Uploaded: 1/9/14

Sources

  1. AC Immune raises CHF 20 million and initiates vaccine trial for Alzheimer’s disease (startupticker.ch) [edit]
Edit This Page
Last Edited 1/9/14

Revision History RSS Picture

Sharing

Share this page on Twitter or Facebook:
Or copy this code to embed a widget: customize »

External Links

CrunchBase API

Sponsors



Become a Sponsor
Terms of Service | Privacy Policy | Licensing Policy